feedback

Activity Chair

Antoni Ribas, MD
Professor of Medicine
Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Los Angeles, CA


Disclosure
Consulting Fee: Amgen, Merck, Novartis, Pfizer
Ownership Interest: Advaxis, Compugen, CytomX, Five Prime, Kite Pharma

Faculty

Caroline Robert, MD, PhD
Head of the Dermatology & Melanoma Clinic
Institute Gustave Roussy
Villejuif, France


Disclosure
Consulting Fee: Amgen, Bristol-Myers Squibb, Merck, Novartis, Roche

Reviewers

Jason Luke, MD

Disclosure:
Consulting Fee: Amgen, Array, EMD Serono
Contracted Research (paid to institution): AbbVie, BBI Therapeutics, Bristol-Myers Squibb, Celldex, Corvus Pharmaceuticals, Delcath, EMD Serono, Five Prime Therapeutics, Genentech, GlaxoSmithKline, Incyte, MedImmune, Merck, Novartis, Pharmacyclics

Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

Disclosure:
No relevant financial relationships to disclose.

Vindico Medical Education Staff: No relevant financial relationships to disclose.

Signed Disclosure(s) are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Provider Statement

This continuing medical education activity is provided by

Activity Details

Credit Type: AMA PRA Category 1 Credit
Credit Amount: 0.75
Release Date: February 1, 2017
Expiration Date: January 31, 2018
Estimated Time to Complete Activity: 45 minutes
Registration Required: No
Fee for Activity: There is no fee for participating in this activity.

Agenda

Introduction and Pretest Antoni Ribas, MD
New and Emerging Concepts in Melanoma Management: Focus on Combination Treatment Caroline Robert, MD, PhD
Case Presentation Antoni Ribas, MD
Posttest and Q&A Moderated by Antoni Ribas, MD

Goals (Purpose) of Program

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is often curable if caught early, treatment options are limited for patients with advanced disease. In almost all cases, death is caused by widespread metastatic disease. Fortunately, an improved understanding of the genetic impact of the disease, earlier detection, appropriate staging, and a treatment revolution that has brought new targeted as well as immunotherapies to clinic has dramatically improved outcomes for patients with metastatic melanoma. In this CME activity, leading oncologists will discuss the latest treatment strategies, clinical advances, as well as clinical evidence for sequencing and combining targeted therapies for the treatment of BRAF-positive metastatic melanoma.

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Implement treatment strategies that reflect patient and disease characteristics as well as the latest clinical advances for the management of BRAF-positive metastatic melanoma.
  • Evaluate the latest clinical evidence for sequencing and combining targeted therapies and immunotherapies for the treatment of BRAF-positive metastatic melanoma.

Target Audience

The intended audience for the activity is oncologists and other health care professionals involved in the treatment of patients with melanoma.

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Commercial Support

This activity is supported by an educational grant from Genentech, Inc.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com

Hardware / Software Requirements

ProCME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.